Efficacy and safety of human papillomavirus vaccine for primary prevention of cervical cancer: A review of evidence from phase III trials and national programs
Data up to Jan 2025
Total Citations Per Year
Abstract
References (22)
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 • 6,072 citations
The causal relation between human papillomavirus and cervical cancer
2002 • 3,451 citations
Against which human papillomavirus types shall we vaccinate and screen? the international perspective
2004 • 1,099 citations
Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
2008 • 1,039 citations
E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.
1996 • 904 citations
Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
2011 • 822 citations
Immune responses to human papillomavirus
2005 • 559 citations
Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
2004 • 541 citations
The Human Papillomavirus E6 protein and its contribution to malignant progression
2001 • 514 citations
Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
2011 • 314 citations
The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme
2011 • 250 citations
Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink
2011 • 218 citations
Efficacy and other milestones for human papillomavirus vaccine introduction
2004 • 214 citations
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine
2011 • 155 citations
Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
2013 • 133 citations
Modifiable Risk Factors Associated with Clearance of Type-Specific Cervical Human Papillomavirus Infections in a Cohort of University Students
2005 • 92 citations
Understanding long‐term protection of human papillomavirus vaccination against cervical carcinoma: Cancer registry‐based follow‐up
2012 • 40 citations
MassARRAY Spectrometry Is More Sensitive than PreTect HPV-Proofer and Consensus PCR for Type-Specific Detection of High-Risk Oncogenic Human Papillomavirus Genotypes in Cervical Cancer
2011 • 32 citations
Human Papillomavirus (HPV) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe?
2013 • 30 citations
Death after Quadrivalent Human Papillomavirus (HPV) Vaccination:Causal or Coincidental?
2016 • 22 citations
Human Papillomavirus (HPV) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe?
2013 • 10 citations
Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
2013 • 5 citations
Cited By (0)
No citing papers found in database